ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
医美概念股
800.232
-18.007
-2.20%
手动刷新
涨家数:
2
跌家数:
7
平家数:
4
市盈率:
- -
高:
820.136
开:
817.507
低:
794.314
收:
818.239
成交量:
5,224.65万
成交额:
4.82亿
市值:
1,348.75亿
流通市值:
971.73亿
数据加载中...
总览
新闻资讯
医药股走低 恒生生物科技指数跌2.48% 映恩生物-B(09606)大跌31.05%
金吾财讯
·
5小时前
昊海生物科技(06826)10月26日斥资55.89万港元回购3.5万股
智通财经
·
昨天
复星医药:控股股东复星高科技解除质押4700万股
南方财经网
·
昨天
瑞丽玉雕工匠上榜!云南新认定培育20个省级劳务品牌
市场资讯
·
10/25
昊海生物科技(06826)前三季度归母净利为约1.63亿元,同比减少46.53%
智通财经
·
10/23
复锐医疗科技(01696)10月23日斥资18.51万港元回购10万股
智通财经
·
10/23
四环医药(00460.HK):轩竹生物(02575.HK)的安奈拉唑钠治疗反流性食管炎III期临床研究数据于UEG Week 2026展示
智通财经
·
10/21
复锐医疗科技(01696)10月21日斥资28.05万港元回购15万股
智通财经
·
10/21
贝莱德在复星医药的H股好仓比例上升0.77%至6.76%
南方财经网
·
10/21
复锐医疗(01696.HK)Profhilo面部适应症注册申请获受理
阿斯达克财经
·
10/21
卓珈控股(01827)股价显著上升11.236%,现价港币$0.99
阿斯达克财经
·
10/21
丽丰控股(01125.HK)公布年度业绩 拥有人应占净亏损约5.92亿港元 同比增长41.1%
智通财经
·
10/20
复锐医疗科技(01696.HK)10月20日耗资约18.31万港元回购10万股
智通财经
·
10/20
贝莱德在复星医药的H股好仓比例上升0.29%至6.28%
南方财经网
·
10/20
四环医药(00460)两款产品相继于香港获批上市
金吾财讯
·
10/20
四环医药:美颜空间生物科技(吉林)研发产品获准在港上市
美股速递
·
10/20
四环医药(00460.HK):渼颜空间自主研发的注射用聚己内酯微球面部填充剂、注射用透明质酸钠复合溶液在香港获批上市
智通财经
·
10/20
时代天使:已在欧洲停用扭矩脊,并以升级版压力点功能替代
美股速递
·
10/17
The Goldman Sachs Group, Inc.增持时代天使(06699.HK)1.72万股 每股作价约81.85港元
智通财经
·
10/16
医思健康(02138)股价上升5.941%,现价港币$0.535
阿斯达克财经
·
10/16
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1593/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":800.2318,"timestamp":1793088499319,"preClose":818.23926,"halted":0,"volume":52246511,"delay":0,"changeRate":-0.022008,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-18.007446,"latestTime":"10-27 16:00:00","open":817.5068,"high":820.1362,"low":794.3137,"amount":481965474,"amplitude":0.031559,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793151000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1793064600000,1793073600000],[1793077200000,1793088000000]],"pbRate":1.11105,"peRate":10.148077,"turnoverRate":0.002131,"increases":1,"decrements":8,"flats":4,"marketCap":134874734936,"floatMarketCap":97173060760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":820.1362,"amplitude":0.031559,"preClose":818.23926,"low":794.3137,"pbRate":"1.11105","latestPrice":800.2318,"volume":52246511,"delay":0,"open":817.5068,"prevYearClose":1094.978,"prevWeekClose":823.766,"prevMonthClose":907.15,"prevQuarterClose":907.15,"fiveDayClose":842.441,"twentyDayClose":880.865,"sixtyDayClose":920.614,"secType":"PLATE","market":"HK","turnoverRate":0.002131,"peRate":10.148077,"marketCap":134874734936,"floatMarketCap":97173060760,"timestamp":1793088499319,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":2,"down":7,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2678140953","title":"医药股走低 恒生生物科技指数跌2.48% 映恩生物-B(09606)大跌31.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678140953","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678140953?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 14:18","pubTimestamp":1793081937,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股走低,恒生生物科技指数大幅跌2.48%。成分股中,映恩生物-B跌31.05%,亚盛医药跌6.70%,科伦博泰生物跌5.96%,三生制药跌5.10%,石药集团跌4.25%,康方生物跌3.63%,中国生物制药跌3.26%,翰森制药跌3.10%,百济神州跌3.03%。近两个月连锁药房密集推出股权激励,驱动板块逻辑从“政策博弈”转向“业绩锚定”。","market":"other","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994559","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","LU0348783233.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1593","HK0000500386.USD","01093","LU1961090484.USD","BK1583","06990","01530","LU0314109678.HKD","LU0315179316.USD","LU0561508036.HKD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU0588546209.SGD","LU0634319403.HKD","IE0008368742.USD","159938","LU1226287529.USD","LU0348766576.USD","LU0501845795.SGD","LU2488822045.USD","LU0417516902.SGD","LU1226287792.SGD","03692","06855","09606","BK1588","09939","LU1969619763.USD","LU0140636845.USD","KURE","LU0417516738.SGD","06160","09926","LU2039709279.SGD","IE0008369823.USD","LU2476274720.SGD","LU1226287875.USD","LU0348827113.USD","01177","LU1993786604.SGD","LU0348784397.USD","BK1515","LU1719994722.HKD","LU0880133367.SGD","HK0000252152.HKD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678083163","title":"昊海生物科技(06826)10月26日斥资55.89万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678083163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678083163?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 16:56","pubTimestamp":1793005003,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)发布公告,于2026年10月26日斥资55.89万港元回购3.5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678168485","title":"复星医药:控股股东复星高科技解除质押4700万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678168485","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678168485?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 16:22","pubTimestamp":1793002956,"startTime":"0","endTime":"0","summary":"南财智讯10月26日电,复星医药公告,公司控股股东复星高科技将其持有的公司4700万股A股办理解除质押手续。本次解除质押后,复星高科技剩余被质押股份数量为5.55亿股,占公司总股本的20.78%;复星高科技及其一致行动人累计质押股份数量为5.55亿股,占其所持公司股份数量的57.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610263907993193.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610263907993193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02196","BK0012","BK1191","BK0096","BK0187","600196","BK1515","BK1593","BK0239","BK0196","BK0028","BK0060","BK0183","BK0188","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678118090","title":"瑞丽玉雕工匠上榜!云南新认定培育20个省级劳务品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2678118090","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678118090?lang=zh_cn&edition=fundamental","pubTime":"2026-10-25 18:04","pubTimestamp":1792922640,"startTime":"0","endTime":"0","summary":"近日云南省人力资源和社会保障厅印发通知新认定培育20个省级劳务品牌其中瑞丽玉雕工匠上榜至此全省共培育打造“滇字号”特色劳务品牌324个其中全国知名劳务品牌7个省级劳务品牌89个带动约860万人就业本次认定的20个品牌覆盖种养殖、制造、居民服务、文旅手工艺、住宿餐饮、新兴产业六大类别,分布于20个县(市、区)。劳务品牌已成为云南促就业、助振兴的重要抓手。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-10-25/doc-iniwmtkq3042523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","02135","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677992257","title":"昊海生物科技(06826)前三季度归母净利为约1.63亿元,同比减少46.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677992257","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677992257?lang=zh_cn&edition=fundamental","pubTime":"2026-10-23 20:32","pubTimestamp":1792758771,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)公布2026年前三季度业绩,营业收入约17.1亿元,同比减少9.93%;归属于上市公司股东的净利润约1.63亿元,同比减少46.53%;基本每股收益0.71元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677292847","title":"复锐医疗科技(01696)10月23日斥资18.51万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677292847","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677292847?lang=zh_cn&edition=fundamental","pubTime":"2026-10-23 18:07","pubTimestamp":1792750078,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复锐医疗科技(01696)发布公告,于2026年10月23日斥资18.51万港元回购10万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01696","BK1100","BK1585","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677674469","title":"四环医药(00460.HK):轩竹生物(02575.HK)的安奈拉唑钠治疗反流性食管炎III期临床研究数据于UEG Week 2026展示","url":"https://stock-news.laohu8.com/highlight/detail?id=2677674469","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677674469?lang=zh_cn&edition=fundamental","pubTime":"2026-10-21 21:01","pubTimestamp":1792587672,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","02575","BK1600","BK1515","00460","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677737196","title":"复锐医疗科技(01696)10月21日斥资28.05万港元回购15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677737196","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677737196?lang=zh_cn&edition=fundamental","pubTime":"2026-10-21 19:17","pubTimestamp":1792581457,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复锐医疗科技(01696)发布公告,于2026年10月21日斥资28.05万港元回购15万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1585","01696","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677624441","title":"贝莱德在复星医药的H股好仓比例上升0.77%至6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677624441","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677624441?lang=zh_cn&edition=fundamental","pubTime":"2026-10-21 17:21","pubTimestamp":1792574477,"startTime":"0","endTime":"0","summary":"南财智讯10月21日电,香港交易所披露信息显示,BlackRock,Inc.(贝莱德)在复星医药的H股好仓(L)比例于10月16日从5.99%上升至6.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610213902716433.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610213902716433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0012","BK0175","BK0096","BK0196","BK0028","BK0188","BK0060","02196","BK0183","BK0187","BK0239","600196","BK1191","BK1515","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677640726","title":"复锐医疗(01696.HK)Profhilo面部适应症注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2677640726","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677640726?lang=zh_cn&edition=fundamental","pubTime":"2026-10-21 14:20","pubTimestamp":1792563600,"startTime":"0","endTime":"0","summary":"复锐医疗科技宣布,旗下Profhilo面部适应症注册申请于9月正式获国家药监局受理。公司并已启动Profhilo在中国市场的全链路商业化筹备,同步开展市场定位、渠道策略、医学教育、终端布局及机构运营等前置工作。Profhilo为高浓度透明质酸钠产品,依托专利NAHYCO技术,采用无BDDE化学交联剂的创新配方,通过生物刺激作用与深层肌肤保湿机制,力求促进胶原蛋白与弹性蛋白再生,目标是改善肌肤质地、提升肌肤紧致度与弹性。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190704152928340_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190704152928340_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1550217/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1550217/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01696","BK1585","BK1593","159891","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677645434","title":"卓珈控股(01827)股价显著上升11.236%,现价港币$0.99","url":"https://stock-news.laohu8.com/highlight/detail?id=2677645434","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677645434?lang=zh_cn&edition=fundamental","pubTime":"2026-10-21 09:45","pubTimestamp":1792547100,"startTime":"0","endTime":"0","summary":"[上升股]卓珈控股(01827) 股价在上午09:45比前收市价显著上升11.236%,现股价为港币$0.99。至目前为止,今日最高价为$0.99,而最低价为$0.955。总成交量为1万股,总成交金额为港币$9900。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144028088_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144028088_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR261021699/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR261021699/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1215","01827","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676693234","title":"丽丰控股(01125.HK)公布年度业绩 拥有人应占净亏损约5.92亿港元 同比增长41.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676693234","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676693234?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 20:16","pubTimestamp":1792498619,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1240","BK1593","01125"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676662354","title":"复锐医疗科技(01696.HK)10月20日耗资约18.31万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676662354","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676662354?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 18:27","pubTimestamp":1792492036,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","BK1593","BK1585","01696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676669466","title":"贝莱德在复星医药的H股好仓比例上升0.29%至6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676669466","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676669466?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 17:21","pubTimestamp":1792488060,"startTime":"0","endTime":"0","summary":"南财智讯10月20日电,香港交易所披露信息显示,BlackRock,Inc.(贝莱德)在复星医药的H股好仓(L)比例于10月14日从5.99%上升至6.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610203901385187.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610203901385187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0012","BK0175","BK0096","BK0196","BK0028","BK0188","BK0060","02196","BK0183","BK0187","BK0239","600196","BK1191","BK1515","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676340666","title":"四环医药(00460)两款产品相继于香港获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2676340666","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676340666?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 16:59","pubTimestamp":1792486780,"startTime":"0","endTime":"0","summary":"金吾财讯 | 四环医药(00460)公告公布,近期,集团旗下渼颜空间生物科技(吉林)有限公司(“渼颜空间”)自主研发及生产的注射用聚己内酯微球面部填充剂(“PCL”)、注射用透明质酸钠复合溶液(FL)(“动能素”),已相继于香港获批上市。此次获批的注射用聚己内酯微球面部填充剂获批规格包括0.5mL╱支、1.0mL╱支、2.0mL╱支;注射用透明质酸钠复合溶液获批规格包括0.5mL╱支、1.0mL╱支、1.5mL╱支、2.0mL╱支、2.5mL╱支、3.0mL╱支、5mL╱盒(内含2支2.5mL╱支规格产品)。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/MGVkMTYyODU4OTM2NDU2Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGVkMTYyODU4OTM2NDU2Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1515","00460","BK1600","BK1191","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188389657","title":"四环医药:美颜空间生物科技(吉林)研发产品获准在港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1188389657","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188389657?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 16:57","pubTimestamp":1792486624,"startTime":"0","endTime":"0","summary":"四环医药宣布,由美颜空间生物科技(吉林)开发的产品已获准在香港市场推出。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","BK1600","BK1191","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676666843","title":"四环医药(00460.HK):渼颜空间自主研发的注射用聚己内酯微球面部填充剂、注射用透明质酸钠复合溶液在香港获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2676666843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676666843?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 16:54","pubTimestamp":1792486454,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1593","BK1600","00460","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137376660","title":"时代天使:已在欧洲停用扭矩脊,并以升级版压力点功能替代","url":"https://stock-news.laohu8.com/highlight/detail?id=1137376660","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137376660?lang=zh_cn&edition=fundamental","pubTime":"2026-10-17 00:05","pubTimestamp":1792166708,"startTime":"0","endTime":"0","summary":"时代天使:公司已在欧洲市场停止使用扭矩脊,转而采用名为压力点的升级功能予以替代。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1100","06699","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675594812","title":"The Goldman Sachs Group, Inc.增持时代天使(06699.HK)1.72万股 每股作价约81.85港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675594812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675594812?lang=zh_cn&edition=fundamental","pubTime":"2026-10-16 19:55","pubTimestamp":1792151711,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","06699","BK1583","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675623035","title":"医思健康(02138)股价上升5.941%,现价港币$0.535","url":"https://stock-news.laohu8.com/highlight/detail?id=2675623035","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675623035?lang=zh_cn&edition=fundamental","pubTime":"2026-10-16 15:59","pubTimestamp":1792137540,"startTime":"0","endTime":"0","summary":"[上升股]医思健康(02138) 股价在下午03:59比前收市价上升5.941%,现股价为港币$0.535。至目前为止,今日最高价为$0.535,而最低价为$0.535。总成交量为2000股,总成交金额为港币$1070。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144025903_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144025903_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610163102/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610163102/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1215","BK1511","BK1593","02138"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}